306
Participants
Start Date
April 30, 2008
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
Pramipexole
Placebo
248.630.04 Boehringer Ingelheim Investigational Site, Beijing
248.630.05 Boehringer Ingelheim Investigational Site, Beijing
248.630.06 Boehringer Ingelheim Investigational Site, Beijing
248.630.07 Boehringer Ingelheim Investigational Site, Beijing
248.630.08 Boehringer Ingelheim Investigational Site, Beijing
248.630.15 Boehringer Ingelheim Investigational Site, Guangzhou
248.630.14 Boehringer Ingelheim Investigational Site, Haerbin
248.630.10 Boehringer Ingelheim Investigational Site, Hangzhou
248.630.09 Boehringer Ingelheim Investigational Site, Nanjing
248.630.12 Boehringer Ingelheim Investigational Site, Qingdao
248.630.01 Boehringer Ingelheim Investigational Site, Shanghai
248.630.02 Boehringer Ingelheim Investigational Site, Shanghai
248.630.03 Boehringer Ingelheim Investigational Site, Shanghai
248.630.16 Boehringer Ingelheim Investigational Site, Suzhou
248.630.13 Boehringer Ingelheim Investigational Site, Wuhan
248.630.11 Boehringer Ingelheim Investigational Site, Xian, Shanxi Province
Lead Sponsor
Boehringer Ingelheim
INDUSTRY